Literature DB >> 2958577

Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia.

Y Otsuki1, E Okamoto, I Iwata, E Nishino, N Mitsuda, M Mori, T Takagi, N Sugita, O Tanizawa.   

Abstract

Changes in concentration of human atrial natriuretic peptide (hANP) in normal and toxaemic pregnancy were examined. The maternal plasma concentration of hANP increased gradually during normal pregnancy to a maximum of 20.0 +/- 2.4 pmol/l (mean +/- S.E.M.) after week 36 of pregnancy. From week 20, the plasma concentrations of hANP were significantly higher than those in non-pregnant women (9.3 +/- 2.0 pmol/l). In toxaemia with hypertension, maternal plasma hANP levels were increased after week 26 of pregnancy (37.7 +/- 6.0 pmol/l) compared with those in normal gravida at the same time (17.1 +/- 1.6 pmol/l). Maternal plasma hANP levels in toxaemia only with oedema were not different from those in normal gravida.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958577     DOI: 10.1677/joe.0.1140325

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Hypothalamic amenorrhea and cardiovascular hormones: changes of plasma calcitonin gene-related peptide and atrial natriuretic peptide levels.

Authors:  F Bernardi; A Valentini; A Margutti; M Santuz; E C Degli Uberti; F Petraglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

2.  Atrial natriuretic factor release during pregnancy in rats.

Authors:  Y Zhang; K Novak; S Kaufman
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

3.  Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide.

Authors:  W Potvin; D R Varma
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  Atrial natriuretic peptide binding in rat placenta, yolk sac, decidua, and maternal placental vessels.

Authors:  J N Scott
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

5.  Inhibition of the tocolytic activity of atrial natriuretic factor by progesterone and potentiation by progesterone receptor antagonist RU486 in rats.

Authors:  W Potvin; S Mulay; D R Varma
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.